Tosoh Bioscience
Japanese bioseparation specialist (est. 1935, TSE: 4042) — TOYOPEARL Protein A, HIC, IEX, SEC resins; TSKgel HPLC columns; alkali-resistant Super A resin for antibody capture; leading Protein A resin supplier globally with low-ligand leaching performance.
- Country
- Japan
- Revenue
- ~¥350B (Tosoh group)
- Employees
- ~700 emp (biosci division)
ISO 9001
FDA DMF
Coverage
| CN | EU | US | |
|---|---|---|---|
| downstream-purification | ✓ | ✓ | ✓ |
Regulatorsfdaema
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Downstream Purification & Bioseparation | downstream-purification | Low | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.